Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atomoxetine Hydrochloride”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00485407
What this trial is testing

Guiding Dose Increases in Patients Incompletely Responsive to Usual Doses of Atomoxetine

Who this might be right for
Attention Deficit Hyperactivity Disorder
Eli Lilly and Company 377
Testing effectiveness (Phase 2)Looking for participantsNCT06899178
What this trial is testing

Atomoxetine in Melanocortin Obesity Syndrome

Who this might be right for
Melanocortin Obesity SyndromeMCOS
Icahn School of Medicine at Mount Sinai 20
Not applicableStudy completedNCT00917371
What this trial is testing

The Effectiveness of Atomoxetine on Brain Imaging, Neuropsychological, and Social Functions in Adults ADHD

Who this might be right for
Attention Deficit Hyperactivity Disorder
National Taiwan University Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00218543
What this trial is testing

Atomoxetine for Treating Cocaine Abuse in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

Who this might be right for
Attention Deficit Disorder With HyperactivityCocaine-Related Disorders
New York State Psychiatric Institute 20
Large-scale testing (Phase 3)Study completedNCT05811247
What this trial is testing

Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo)

Who this might be right for
OSA
Apnimed 660
Large-scale testing (Phase 3)Enrolling By InvitationNCT06566820
What this trial is testing

Continuation Protocol for Obstructive Sleep Apnea (OSA)

Who this might be right for
OSA
Apnimed 1,280
Large-scale testing (Phase 3)Study completedNCT00191516
What this trial is testing

An Open-Label Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder

Who this might be right for
Attention Deficit Hyperactivity Disorder
Eli Lilly and Company 257
Not applicableStudy completedNCT00286949
What this trial is testing

Treatment of Executive Dysfunction in Parkinson's Disease

Who this might be right for
Parkinson's Disease
Johns Hopkins University 12
Post-approval studies (Phase 4)Study completedNCT00191035
What this trial is testing

Maintenance of Benefit With Atomoxetine Hydrochloride in Adolescents With ADHD

Who this might be right for
Attention-Deficit/Hyperactivity Disorder
Eli Lilly and Company 520
Early research (Phase 1)Ended earlyNCT01343628
What this trial is testing

A Gene by Medication Interaction to the Acute Effects of Alcohol

Who this might be right for
Alcohol-induced Cue-cravingAlcohol Sensitivity
University of Virginia 43
Post-approval studies (Phase 4)Study completedNCT00191633
What this trial is testing

Study of Atomoxetine in Children With ADHD to Assess Symptomatic and Functional Outcomes

Who this might be right for
Attention-Deficit/Hyperactivity Disorder
Eli Lilly and Company 200
Testing effectiveness (Phase 2)Study completedNCT01863251
What this trial is testing

Atomoxetine for ATS and Opioid Dependence During Buprenorphine Maintenance Treatment in Malaysia

Who this might be right for
Opiate DependenceStimulant Dependence
Yale University 90
Post-approval studies (Phase 4)Study completedNCT02287038
What this trial is testing

Atomoxetine in Veterans With Comorbid ADHD/PTSD

Who this might be right for
Post Traumatic Stress DisorderAttention Deficit Hyperactivity Disorder
VA Office of Research and Development 44
Post-approval studies (Phase 4)Study completedNCT00176436
What this trial is testing

Atomoxetine for Treatment of Weight Gain in Olanzapine or Clozapine Patients

Who this might be right for
Schizophrenia
University of Maryland, Baltimore 40
Post-approval studies (Phase 4)Study completedNCT00190736
What this trial is testing

Efficacy and Safety of Once-Daily Atomoxetine Hydrochloride in Adults With ADHD Over an Extended Period of Time (6 Months)

Who this might be right for
ADHD
Eli Lilly and Company 440
Not applicableUnknownNCT03075579
What this trial is testing

Atomoxetine, Diurnal Profiles of Cortisol and α-amylase

Who this might be right for
ADHD
Praxis für kleine und grosse Leute 50
Large-scale testing (Phase 3)Study completedNCT00386581
What this trial is testing

Efficacy, Tolerability, and Safety of Once-Daily Atomoxetine Hydrochloride Versus Placebo in Russian Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

Who this might be right for
Attention Deficit Disorder With Hyperactivity
Eli Lilly and Company 105
Post-approval studies (Phase 4)Study completedNCT00304161
What this trial is testing

Effectiveness of Antidepressant Treatment for Depression in People With Parkinson's Disease

Who this might be right for
Depressive DisorderParkinson Disease
University of Pennsylvania 55
Post-approval studies (Phase 4)Study completedNCT00485849
What this trial is testing

Atomoxetine for Attention Deficit and Hyperactive/Impulsive Behaviour Problems in Children With ASD

Who this might be right for
Attention Deficit Hyperactivity Disorder
Eli Lilly and Company 12
Early research (Phase 1)Ended earlyNCT01019707
What this trial is testing

Safety Assessment of Atomoxetine With MA IV Administration

Who this might be right for
Methamphetamine AbuseMethamphetamine Dependence
University of California, Los Angeles 6
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation